Endotronix, a medical technology company focused on heart failure treatment, announced Thursday that it plans to move its headquarters from Lisle to Naperville’s HUB 1415 building at 1415 Diehl Road.
The company’s new headquarters will be twice the size of its current building, allowing for a 30 percent increase in its workforce.
The new facility is over 80,000 square feet and is currently undergoing construction for custom enhancements, including a state-of-the-art cleanroom, manufacturing, quality and administrative space. The headquarters is also being specifically designed to enable flexible working hours in a hybrid model. Construction on the building’s first phase is expected to finish early next year.
“This is an exciting time for Endotronix. As we approach full enrollment in our PROACTIVE-HF clinical trial, we are looking ahead toward scaling our manufacturing and operations in anticipation of commercialization of our proactive digital heart failure system,” Endotronix CEO Harry Rowland said in a statement. “Naperville offers an ideal location to plant our roots, offering a skilled workforce, affordable quality of life for our employees, desirable proximity to Chicago and strong sense of community.”
Endotronix offers a comprehensive, reimbursable health management platform, the Cordella Heart Failure System, for patients with advanced heart failure. The company has also developed an implantable wireless pulmonary artery pressure sensor currently ongoing clinical trials. If approved by the FDA, the sensor would be able to detect early signs of worsening heart failure.
